Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company, focused on developing therapies for the treatment of high-impact, difficult-to-treat ...

Moleculin Biotech, Inc. , (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat cancers and viruses, ...

Alnylam Pharmaceuticals, Inc. , the leading RNAi therapeutics company, announced today that it will report financial results for the first quarter ending March 31, 2025 on Thursday, May 1, 2025, ...

Artificial intelligence is fast becoming an integral part of everyday life. But as the technology explodes, the debate ...

Industry experts are predicting a bright spot of good news about the drone industry value in 2025. New estimates project that the global drone market will be worth $57.8 billion by 2030. That's a huge ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

China's unrivaled EV market lead China has rapidly become the world's electric vehicle powerhouse, both as a producer and ...

"Some days I still can't believe I built this on my own," they added. "I love my tiny home on wheels." Whether you choose to ...

One concerned parent offered an emotional take on what they've experienced while learning about food dyes. "The hardest part, ...

Three Gallaudet Biology students won honors and cash prizes in this year's NASA DC Space Grant Consortium’s student poster ...

MOMA Therapeutics, a clinical-stage biopharmaceutical company discovering and developing a new generation of precision therapeutics, today announced three poster presentations at the 2025 American ...

Undergraduate Research Showcase, April 15, 2025. The spring Undergraduate Research Showcase is one of the highlights of April ...